LOGEX Netherlands notes that the European Commission closed a joint funding agreement with participating countries to provide access to up to 24 million RSV vaccine doses over the next four years.
Public source
Publisher name
Public post
🫁 Europa breidt de toegang tot RSV-preventie uit. Nu rijst de cruciale vraag: welke strategieën leveren in de praktijk de grootste impact op? Elk jaar legt het respirat…
Company
LOGEX Netherlands
Turning data into better healthcare, that is our mission.
- Industry
- Technology, Information and Internet
- Location
- Amsterdam, NL
- Company size
- 51–200 employees
About LOGEX Netherlands
Turning data into better healthcare, that is our mission. We empower stakeholders at every level of the healthcare system by bringing clarity to decisions that result into the best possible healthcare. LOGEX is headquartered in Amsterdam, with over 350 international experts working in ten countries across Europe. To learn how LOGEX can bring clarity to your healthcare data, visit logex.com.
See moreLatest activity
Latest activity from LOGEX Netherlands
2 signals
Discover more
Similar signals
Similar public activity from other companies.
Research & Knowledge
Health Holland
Health Holland published a new Insight by Strategie Manager Marquerite Sallons exploring the transition from care to health and how health innovation can contribute to a system that is both more efficient and more patient-friendly.
Research & Knowledge
ZonMw
ZonMw, together with NWO, is hosting a research activity to bring the bacteriofagen and bacteriofaagtherapie ecosystem in the Netherlands to the public.
Research & Knowledge
Apothekersorganisatie KNMP
Apothekersorganisatie KNMP opened a consultation for the Openbaar apotheker 2030 vision.
Research & Knowledge
De Zorggroep
De Zorggroep reports that the Zorg on Afstand team in the sector Thuis in the Netherlands reached an average of 2.325 meetings per month via beeldzorg in the end of 2025.
Research & Knowledge
College ter Beoordeling van Geneesmiddelen